Cited by 552Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesSmoking Behavior and Cessation

The DOI matches its Crossref record; 340 of the 341 references it cites were found in a registry or an index.

Cannabis use and cannabis use disorder

Open access

Connor, Jason P., Stjepanović, Daniel, Le Foll, Bernard, Hoch, Eva, Budney, Alan J., Hall, Wayne D.·2021·Nature Reviews Disease Primers

DOI 10.1038/s41572-021-00247-4PMC PMC8655458

Open this paper in CoChat — free account

Abstract

Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10% of the 193 million cannabis users worldwide. The individual and public health burdens are less than those of other forms of drug use, but CUD accounts for a substantial proportion of persons seeking treatment for drug use disorders owing to the high global prevalence of cannabis use. Cognitive behavioural therapy, motivational enhancement therapy and contingency management can substantially reduce cannabis use and cannabis-related problems, but enduring abstinence is not a common outcome. No pharmacotherapies have been approved for cannabis use or CUD, although a number of drug classes (such as cannabinoid agonists) have shown promise and require more rigorous evaluation. Treatment of cannabis use and CUD is often complicated by comorbid mental health and other substance use disorders. The legalization of non-medical cannabis use in some high-income countries may increase the prevalence of CUD by making more potent cannabis products more readily available at a lower price. States that legalize medical and non-medical cannabis use should inform users about the risks of CUD and provide information on how to obtain assistance if they develop cannabis-related mental and/or physical health problems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41572-021-00247-4

Cites

340 of 340 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Timeline Follow-Back
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
ADOLESCENT RESILIENCE: A Framework for Understanding Healthy Development in the Face of Risk
Fergus, S., & Zimmerman, M. A. (2004) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144357 · Cited by 3,243
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Show all 341 references

Research works printed but not linked: 13

Hall, W., Renström, M. & Poznyak, V. The Health and Social Effects of Nonmedical Cannabis Use (World Health Organization, 2016). This is a seminal review of the short-term and long-term effects of cannabis use and CUD on health.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, & Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (National Academies Press, 2017).
Compton, W. M. & Han, B. in The Complex Connection between Cannabis and Schizophrenia (eds Compton, M. & Manseau, M.) (Academic Press, 2017).
Connor, J. P., Feeney, G. F. X., Kelly, A. B. & Saunders, J. B. in The SAGE Handbook of Drug & Alcohol Studies. Volume 2, 283–305 (SAGE Publications, 2016).
Howlett, A. C. in Cannabinoids. Handbook of Experimental Psychology, vol 168 (ed. Pertwee, R. G.) 53–79. (Springer, 2005).
Trick, L. et al. in PET and SPECT in Psychiatry 2nd edn (eds Dierckx, R. A. J. O., Otte, A., de Vries, E. F. J., van Waarde, A. & Sommer, I. E.) 653–712 (Springer, 2020).
McMurran, M. The Psychology of Addiction (Routledge, 1994).
American Psychiatric Association. Substance-related and addictive disorders. in Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2013). · DOI · Paper page
Connor, J. P., Saunders, J. B. & Feeney, G. F. X. in Quality of Life in Mental Disorders (eds Katschnig, H., Freeman, H. L. & Sartorius, N.) 199–208 (John Wiley & Sons, 2006).
Longabaugh, R., Magill, M., Morgenstern, J. & Huebner, R. in Addictions: A Comprehensive Guidebook (eds McCrady, B. S. & Epstein, E. E.) 572–596 (Oxford University Press, 2013).
Marlatt, G. A., & Donovan, D. M. (eds) Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors (Guilford Press, 1985).
Saunders, J. B. et al. (eds) Addiction Medicine (Oxford University Press, 2016).
Ries, N. M. Prescribe with caution: the response of canada’s medical regulatory authorities to the therapeutic use of cannabis. McGill J. Law Health 9, 215–254 (2016).

Sorted by citations

Items 101–200 of 552

Climbing the Evidence Pyramid: Dosing Considerations for Medical Cannabis in the Management of Chronic Pain
Jugl, S., Goodin, A. J., & Brown, J. D. (2023) · Medical Cannabis and Cannabinoids · doi:10.1159/000530251 · Cited by 9
Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies
Xiao, K. B., Grennell, E., Ngoy, A., George, T. P., Foll, B. L., Hendershot, C. S., & Sloan, M. E. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06360-4 · Cited by 9
Women are taking the hit: Examining the unique consequences of cannabis use across the female lifespan
Gräfe, E. L., Reid, H. M. O., Shkolnikov, I., Conway, K., Kit, A., Acosta, C., & Christie, B. R. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101076 · Cited by 10
Gut bacteria, endocannabinoid system, and marijuana addiction: Novel therapeutic implications
Pinapati, K. K., Vidya, S., Khan, M. F., Mandal, D., & Banerjee, S. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100144 · Cited by 9
Cannabis use disorder and perioperative outcomes following complex cancer surgery
Munir, M. M., Woldesenbet, S., Endo, Y., Dillhoff, M. E., & Pawlik, T. M. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.27644 · Cited by 9
Precision Mental Health Care for Cannabis Use Disorder: Utility of a bioSocial Cognitive Theory to Inform Treatment
Gullo, M. J., Papinczak, Z. E., Feeney, G. F. X., Young, R. M., & Connor, J. P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.643107 · Cited by 9
Preliminary Eye-Tracking Data as a Nonintrusive Marker for Blood Δ-9-Tetrahydrocannabinol Concentration and Drugged Driving
Zandi, A. S., Comeau, F. J. E., Mann, R. E., Ciano, P. D., Arslan, E. P., Murphy, T., Foll, B. L., & Wickens, C. M. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0141 · Cited by 9
Cannabis use and psychosis susceptibility: A call to action
Batalla, A., & Maat, A. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.09.004 · Cited by 9
Prediction of adverse events risk in patients with comorbid post-traumatic stress disorder and alcohol use disorder using electronic medical records by deep learning models
Miranda, O., Fan, P., Qi, X., Wang, H., Brannock, D., Kosten, T. R., Ryan, N. D., Kirisci, L., & Wang, L. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111066 · Cited by 9
The Legalisation of Cannabis in South Africa: Proposing an Economic Value Chain Model for South Africa
Gwala, R. S. (2023) · Advances in Business Strategy and Competitive Advantage · doi:10.4018/978-1-6684-6346-8.ch006 · Cited by 8
Cannabis Use Does Not Affect Outcomes After Total Hip Arthroplasty
Hegde, V. V., Bracey, D. N., Pollet, A. K., Farsad, Y. Y., Dennis, D. A., & Jennings, J. M. (2023) · The Journal of Arthroplasty · doi:10.1016/j.arth.2023.03.040 · Cited by 8
Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019
Mauro, P. M., Gutkind, S., Askari, M. S., Hasin, D. S., Samples, H., Mauro, C., Annunziato, E. M., Boustead, A. E., & Martins, S. S. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111113 · Cited by 10
Association between history of cannabis use and outcomes after total hip or knee arthroplasty: a systematic review and meta-analysis
Yang, G., Li, F., Wang, Q., Liu, Y., Guo, J., & Chen, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1377688 · Cited by 8
Role of Cannabis in the Management of Chronic Non-Cancer Pain: A Narrative Review
Al-Husinat, L., Obeidat, S., Azzam, S., Al-Gwairy, Y., Obeidat, F., Sharie, S. A., Haddad, D., Haddad, F. F., Rekatsina, M., Leoni, M. L. G., et al. (2025) · Clinics and Practice · doi:10.3390/clinpract15010016 · Cited by 9
Selected Use of Complementary and Alternative Medicine (CAM) Agents in IBD
Dzwonkowski, M., Bahirwani, J. T., Rollins, S., Muratore, A., Christian, V. J., & Schneider, Y. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-00960-0 · Cited by 8
Cannabis use disorder: an overview of treatment approaches in Europe
Hoch, E., Murawski, M., Ferri, M., & Feingold, D. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-01964-7 · Cited by 10
A Holistic Review of Cannabis and Its Potential Risks and Benefits in Mental Health
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Psychiatry International · doi:10.3390/psychiatryint6030092 · Cited by 13
Cannabis Use in Adolescent and Young Adult Athletes: A Clinical Review
Benoy, R., Ramirez, C., Hitchcock, M., & Reardon, C. L. (2023) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381231208661 · Cited by 8
Cannabis Use Disorder Trends and Health Care Utilization After Cervical and Lumbar Spine Fusions
Dietz, N. E., Alkin, V., Agarwal, N., Sharma, M., Oxford, B. G., Wang, D., Ugiliweneza, B., Mettille, J., Boakye, M., & Drazin, D. G. (2023) · Spine · doi:10.1097/brs.0000000000004874 · Cited by 8
Cannabis Use Differences Among Sexual Minority Versus Heterosexual Females and Males in Oklahoma: The Roles of Mental Health, Cannabis Perceptions, and Cannabis Marketing Exposure
Romm, K. F., Ehlke, S. J., Smith, M., Vogel, E. A., McQuoid, J., Kendzor, D. E., & Cohn, A. M. (2023) · Substance Use & Addiction Journal · doi:10.1177/29767342231208519 · Cited by 8
Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis
Mosandl, C. F., Baltes‐Flueckiger, L., Kronschnabel, J., Meyer, M., Guessoum, A., Herrmann, O., Vogel, M., Walter, M., & Pichler, E. M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1356988 · Cited by 8
The Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Life · doi:10.3390/life15060834 · Cited by 12
Cannabis Use and the Development of Depression in Adolescents: Is There an Established Linear Relationship Between the Two?
White, C. T., Shamim, H., Shouli, R. A., Habbal, A. B., & Mohammed, L. (2022) · Cureus · doi:10.7759/cureus.27394 · Cited by 8
Exploring opportunities for drug repurposing and precision medicine in cannabis use disorder using genetics
Greco, L. A., Reay, W. R., Dayas, C. V., & Cairns, M. J. (2023) · Addiction Biology · doi:10.1111/adb.13313 · Cited by 6
Visions of Cannabis Control
Heidt, J., & Wheeldon, J. (2023) · doi:10.1093/oso/9780198875215.001.0001 · Cited by 9
Cortical Morphology in Cannabis Use Disorder: Implications for Transcranial Direct Current Stimulation Treatment
Soleimani, G., Towhidkhah, F., Saviz, M., & Ekhtiari, H. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.3400.1 · Cited by 8
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study
Zhang, Y., Ni, Y., & Li, L. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111037 · Cited by 7
Use of Cannabis for Medical or Recreational Purposes Among US Young Adults: Correlates and Implications for Problematic Use and Interest in Quitting
Sridharan, P., Romm, K. F., & Berg, C. J. (2024) · Cannabis · doi:10.26828/cannabis/2024/000216 · Cited by 7
Cannabis for medicine and food: A benefit vs risk critical appraisal
Nethengwe, M., Maphosa, Y., Ahiante, B., & Oyenihi, A. B. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.09.069 · Cited by 8
Natural compounds for endometriosis and related chronic pelvic pain: A review
Zaurito, A., Mehmeti, I., Limongelli, F., Zupo, R., Annunziato, A., Fontana, S., & Tardugno, R. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106277 · Cited by 10
Effect of recreational cannabis use on bone mineral density: a systematic review
Magno, L. A. V., Tameirão, D. R., Alves, L. F., & Guimarães, N. S. (2023) · Osteoporosis International · doi:10.1007/s00198-023-06992-4 · Cited by 9
Cannabis use disorder is associated with shorter length of stay and increased home discharge after primary total joint arthroplasty: a propensity-weighted analysis
Rahmon, D., Zalikha, L., Mazur, M., Hussein, I. H., & El‐Othmani, M. M. (2023) · Arthroplasty · doi:10.1186/s42836-023-00164-9 · Cited by 7
Unravelling a novel role for cannabidivarin in the modulation of subventricular zone postnatal neurogenesis
Lourenço, D. M., Soares, R., Santos, S. S., Mateus, J. M., Rodrigues, R. S., Moreira, J. B., Vaz, S. H., Sebastião, A. M., Solá, S., & Xapelli, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176079 · Cited by 7
Cannabiskonsum im Teenageralter: Ergebnisse des Präventionsradars von 2016 bis 2023
Hanewinkel, R., & Hansen, J. (2024) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2256-5062 · Cited by 7
Age differences in patterns of cannabis use among an online US sample of adults who consume cannabis frequently
Livne, O., Budney, A. J., Borodovsky, J. T., Shmulewitz, D., Walsh, C. A., Struble, C. A., Habib, M. I., Aharonovich, E., & Hasin, D. S. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2309340 · Cited by 7
Cannabis use and cannabis use disorders and their treatment in the Europe
Hall, W., Manthey, J., & Stjepanović, D. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01776-1 · Cited by 6
Avatar Intervention in Virtual Reality for Cannabis Use Disorder in Individuals With Severe Mental Disorders: Results From a 1-Year, Single-Arm Clinical Trial
Giguère, S., Beaudoin, M., Dellazizzo, L., Phraxayavong, K., Potvin, S., & Dumais, A. (2024) · JMIR Mental Health · doi:10.2196/58499 · Cited by 10
White matter alterations associated with chronic cannabis use disorder: a structural network and fixel-based analysis
Maleki, S., Hendrikse, J., Richardson, K., Segrave, R. A., Hughes, S., Kayayan, E., Oldham, S., Syeda, W., Coxon, J., Caeyenberghs, K., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03150-0 · Cited by 8
Substance Use Related to School Dropout: A Systematic Review and Meta‐Analysis
Zhu, D., Wang, F., Wang, S., Cao, L., Tong, Y., Xie, F., Wang, G., & Su, P. (2025) · Psychology in the Schools · doi:10.1002/pits.23442 · Cited by 6
Patterns of past month cannabis consumption and cannabis use disorder – Insights from a nationally representative survey
Kritikos, A. F., Taylor, B. G., Lamuda, P. A., Pollack, H. A., & Schneider, J. A. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112680 · Cited by 6
Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder
Ney, L. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125527 · Cited by 6
Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescents
Skumlien, M., Jones, D., Mokrysz, C., Lees, R., Petrilli, K., Ofori, S., Lawn, W., Curran, H. V., & Freeman, T. P. (2025) · Communications Medicine · doi:10.1038/s43856-025-01018-y · Cited by 6
Precision Adjuvant Strategies in Vaccine Development for Substance Use Disorders: Variability and Mechanistic Insights
Bian, Y., Ci, Q., Luo, X., & Zhang, C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091223 · Cited by 8
The association between preconception cannabis use and depression and anxiety during pregnancy
Leng, Q. L., Lo, J. O.-T., Rakshe, S. K., Hildebrand, A. D., Doyle, O. J., Seghete, K. L. M., & Graham, A. M. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.05.006 · Cited by 6
Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates.
Martin‐Willett, R., Skrzynski, C. J., Karoly, H. C., Elmore, J. S., & Bidwell, L. C. (2023) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000667 · Cited by 6
Ketamine for Adults With Substance Use Disorders
Tran, K. T., & MacDougall, D. (2024) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2024.845 · Cited by 6
IgE-Mediated Allergy and Asymptomatic Sensitization to Cannabis Allergens—Review of Current Knowledge and Presentation of Six Cases
Wąsik, J., Likońska, A., & Kurowski, M. M. (2024) · Medicina · doi:10.3390/medicina60060954 · Cited by 6
Significant Psychedelic Experiences Evaluated for Mystical Characteristics Associated with Cannabis Use Reduction and Psychological Flexibility Improvement: A Naturalistic Cross-Sectional Retrospective Survey
Roméo, B., Kervadec, E., Fauvel, B., Strika-Bruneau, L., Amirouche, A., Verroust, V., Piolino, P., & Benyamina, A. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2375720 · Cited by 6
“I don’t need my kid to be high”: prioritizing harm reduction when using cannabis during pregnancy
Gould, E. E., Ganesh, S. S., & Ceasar, R. C. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01046-2 · Cited by 6
Anabolic-androgenic steroid use disorder: case for recognition as a substance use disorder with specific diagnostic criteria
Scarth, M., Havnes, I. A., & Bjørnebekk, A. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.73 · Cited by 6
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial
Montebello, M. E., Jefferies, M., Mills, L., Bruno, R., Copeland, J., McGregor, I. S., Rivas, C., Jackson, M. A., Silsbury, C., Dunlop, A. J., et al. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109388 · Cited by 6
Association between ABCB1 rs2235048 Polymorphism and THC Pharmacokinetics and Subjective Effects following Smoked Cannabis in Young Adults
Matheson, J., Zhang, Y. J., Brands, B., Wickens, C. M., Tiwari, A. K., Zai, C. C. H., Kennedy, J. L., & Foll, B. L. (2022) · Brain Sciences · doi:10.3390/brainsci12091189 · Cited by 6
Negative experiences of patients using medicinal cannabis: A systematic review of qualitative studies
Gliksberg, O., Kushnir, T., Sznitman, S. R., Lev‐Ran, S., Brill, S., Amit, B. H., & Feingold, D. (2023) · Journal of Clinical Nursing · doi:10.1111/jocn.16653 · Cited by 6
Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder
Phan, A. N., & Terry, G. E. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1144276 · Cited by 6
Early, Chronic, and Acute Cannabis Exposure and Their Relationship With Cognitive and Behavioral Harms
López‐Pelayo, H., Campeny, E., Oliveras, C., Rehm, J. T., Manthey, J., Gual, A., & Balcells‐Oliveró, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.643556 · Cited by 7
Integrating Positive Psychology into Substance Use Treatments
Stone, B. M. (2023) · Encyclopedia · doi:10.3390/encyclopedia3030082 · Cited by 8
The Effect of Mindfulness-based Psychoeducation on Negative Automatic Thoughts and Medication Adherence in Individuals with Cannabis Use Disorder: a Randomized Controlled Trial
Budak, F. K., Akbeniz, A., Erkan, F. M., Gültekin, A., & Cumurcu, H. B. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01282-4 · Cited by 5
A Scoping Review of Interventions for U.S. College Students’ Harmful Cannabis Use and a Call for a College Cannabis Intervention Matrix
Hone, L. S. E., Boness, C. L., Helle, A. C., Kilmer, J. R., Morgan‐Daniel, J., Chance, S. M., Rohleen, T. K., & Cronce, J. M. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01361-6 · Cited by 5
Cannabinoid Hyperemesis Syndrome (CHS) - An emerging gastrointestinal disorder and clinical challenge
McFee, R. B. (2024) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101832 · Cited by 5
Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis
Predescu, I.-A., Jîjie, A.-R., Pătrașcu, D., Pasc, A.-L.-V., Piroș, E. L., Trandafirescu, C. M., Oancea, C. I., Dehelean, C. A., & Moacă, E.-A. (2025) · Pharmacy · doi:10.3390/pharmacy13010007 · Cited by 7
Sex differences in the acute effects of cannabis on human cognition: A systematic review
Matheson, J., Behzad, D., Zakala, C., Hawken, T., Brands, B., Foll, B. L., Wickens, C. M., Ruocco, A. C., Rodak, T., & Ciano, P. D. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101215 · Cited by 5
Incidence and risk factors for native vertebral osteomyelitis: a retrospective cohort study using a National Claims Database
Channer, L. J., Krol, O. F., Philipp, T. C., Wright, C. H., Kark, J. A., Smith, S. J., & Yoo, J. U. (2025) · The Spine Journal · doi:10.1016/j.spinee.2025.10.002 · Cited by 5
Cigarette and cannabis use and co-use among U.S. adults: An examination of prevalence and trends during 2015–2023
Constantin, J., & Jayawardhana, J. (2025) · Addictive Behaviors · doi:10.1016/j.addbeh.2025.108521 · Cited by 5
Cannabis Use Disorder in the Era of Legalization: Implications for Addiction Treatment Systems
Bahji, A. (2026) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s581271 · Cited by 5
Exploring the Role of DARPP-32 in Addiction: A Review of the Current Limitations of Addiction Treatment Pathways and the Role of DARPP-32 to Improve Them
Greener, M.-R., & Storr, S. J. (2022) · NeuroSci · doi:10.3390/neurosci3030035 · Cited by 5
Cannabis Abuse Is Associated With Greater Medical Complications, Emergency Department Visits, and Readmissions Following Open Reduction and Internal Fixation for Distal Radius Fractures
Gordon, A. M., Golub, I. J., Diamond, K. B., Kang, K. K., & Choueka, J. (2023) · Hand · doi:10.1177/15589447231210948 · Cited by 5
Density of cannabis outlets vs. cannabis use behaviors and prevalent cannabis use disorder: findings from a nationally-representative survey
Wichaidit, W., Chapakiya, I., Waeuseng, A., Chumchuen, K., & Assanangkornchai, S. (2024) · PeerJ · doi:10.7717/peerj.17317 · Cited by 5
Spatial Craving Patterns in Marijuana Users: Insights From fMRI Brain Connectivity Analysis With High-Order Graph Attention Neural Networks
Ding, J.-E., Yang, S., Zilverstand, A., Kulkarni, K. R., Gu, X., & Liu, F. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3462371 · Cited by 5
Drug interactions in a sample of inpatients diagnosed with cannabis use disorder
Westhoff, M. S., Massarou, C., Bleich, S., Heck, J., Jendretzky, K. F., Glahn, A., & Schröder, S. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02884-5 · Cited by 5
Role of the Endocannabinoid System in Fibromyalgia
García‐Domínguez, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040230 · Cited by 7
Cannabis Vaping in Youth: A Systematic Review and Meta-Analysis of Risk Factors in Adolescents and Young Adults
Chung, J. Y. C., Lim, C. C. W., Leung, J., Stjepanović, D., Chiu, V., Hides, L. M., Connor, J. P., Hall, W., & Chan, G. (2025) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.24-00464 · Cited by 5
An exploration of multivariate symptom clusters of cannabis use disorder in young adults
Howe, L. K., Bailey, A. J., Ingram, P., & Finn, P. (2022) · Addictive Behaviours · doi:10.1016/j.addbeh.2022.107465 · Cited by 4
Longitudinal Relationship between the Introduction of Medicinal Cannabis and Polypharmacy: An Australian Real‐World Evidence Study
Kalaba, M., Eglit, G. M. L., Feldner, M. T., Washer, P., Ernenwein, T., Vickery, A. W., & Ware, M. A. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/8535207 · Cited by 5
Monitoring adherence and abstinence of cannabis use disorder patients: Profile identification and relationship with long-term treatment outcomes
Dacosta‐Sánchez, D., Fernández‐Calderón, F., Blanc, A., Díaz, C., & Lozano, O. M. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.209019 · Cited by 5
Cost-Effectiveness of Medical Cannabis Versus Opioids for Chronic Noncancer Pain
Jeddi, H. M., Busse, J. W., Sadeghirad, B., Levine, M., MacCallum, C. A., Wang, L., Couban, R., & Tarride, J. (2025) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0120 · Cited by 5
Cannabis and the Heart: Unchartered Territory
Parikh, K., Patel, M. A., Bansal, T., Raco, J., Gupta, S., Jain, R., & Jain, R. (2022) · Future Cardiology · doi:10.2217/fca-2022-0018 · Cited by 5
Cannabis: Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin
Canseco-Alba, A., & Rodrı́guez–Manzo, G. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000112 · Cited by 6
COVID-19 Vaccine Hesitancy in India: An Exploratory AnalysisPreprint
Agarwal, S., & Naha, M. (2021) · medRxiv · doi:10.1101/2021.09.15.21263646 · Cited by 5
Help-seeking behaviours among cannabis consumers in Canada and the United States: Findings from the international cannabis policy study
Rundle, S. M., & Hammond, D. G. (2024) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2024.100306 · Cited by 4
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era
Bahji, A. (2025) · Addiction · doi:10.1111/add.70274 · Cited by 4
Lifespan changes in cannabinoid 1 receptor mRNA expression in the female C57BL/6J mouse brain
Li, X., Zhao, G., Huang, H., Ye, J., Xu, J., Zhou, Y., Zhu, X., Wang, L., & Wang, F. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25427 · Cited by 4
Incremental Predictive Validity of the Dualistic Model of Passion for Cannabis Use Among College Undergraduate Students With and Without a Cannabis Use Disorder
Davis, A. K., Arterberry, B. J., Xin, Y., Hubbard, S. M., Schwarting, C. M., & Bonar, E. E. (2023) · Cannabis · doi:10.26828/cannabis/2023/000180 · Cited by 4
Cannabis Science and Therapeutics: An Overview for Clinicians
Sera, L., & Hempel-Sanderoff, C. (2023) · Journal of clinical pharmacology · doi:10.1002/jcph.2400 · Cited by 2
Acute Cannabis Administration Transiently Reduces Mitochondrial DNA in Young Adults: Findings from a Secondary Analysis of a Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Powlowski, P., Matheson, J., Foll, B. L., Andreazza, A. C., & Ross, R. A. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0282 · Cited by 4
Conceptualizing problematic use of medicinal Cannabis: Development and preliminary validation of a brief screening questionnaire
Feingold, D., Gliksberg, O., Brill, S., Amit, B. H., Lev‐Ran, S., Kushnir, T., & Sznitman, S. R. (2024) · Addictive Behaviors · doi:10.1016/j.addbeh.2024.108122 · Cited by 5
A Systematic Review of Delta-9-Tetrahydrocannabinol (∆9-THC) in Astrocytic Markers
Ramos-Jiménez, C., Petkau, S., & Mizrahi, R. (2024) · Cells · doi:10.3390/cells13191628 · Cited by 4
The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol
Buschner, M., Heckel, N., Duerler, P., Engeli, E. J. E., Schneider, S., Havelka, E. M., Nordt, C., & Herdener, M. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104610 · Cited by 4
Parental influence on youth cannabis use: The interplay between disapproval and warmth
Young, B. R., Wheeler, L. A., & Dai, H. D. (2025) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2025.100621 · Cited by 6
Association between Polymorphism rs1799732 of DRD2 Dopamine Receptor Gene and Personality Traits among Cannabis Dependency
Chmielowiec, J., Chmielowiec, K., Masiak, J., Śmiarowska, M., Strońska-Pluta, A., Dziedziejko, V., & Grzywacz, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191710915 · Cited by 4
Regular Cannabis Use During the First Year of the Pandemic: Studying Trajectories Rather Than Prevalence
Lee, J. O., Lee, W. J., Kritikos, A. F., Jin, H., Leventhal, A. M., Pedersen, E. R., Cho, J., Davis, J. P., Kapteyn, A., Wilson, J. P., et al. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.01.035 · Cited by 5
Implementation and Preliminary Evaluation of a 12-Week Cognitive Behavioural and Motivational Enhancement Group Therapy for Cannabis Use Disorder
Trick, L., Butler, K., Bourgault, Z., Vandervoort, J., & Foll, B. L. (2023) · Substance Abuse Research and Treatment · doi:10.1177/11782218231205840 · Cited by 4
Adverse Childhood Experiences and Problematic Cannabis Use: The Role of Emotion Dysregulation and Affective Impulsivity
Vieira, J. L., Snaychuk, L. A., Milicevic, J., Hodgins, D. C., Shead, N. W., Keough, M. T., & Kim, A. (2023) · Cannabis · doi:10.26828/cannabis/2023/000190 · Cited by 4
Therapeutic Potential of Cannabinoid Profiles Identified in Cannabis L. Crops in Peru
Wong-Salgado, P., Soares, F. L., Moya-Salazar, J., Ramírez-Méndez, J. F., Moya-Salazar, M. M., Apesteguía, A., & Castro, A. (2024) · Biomedicines · doi:10.3390/biomedicines12020306 · Cited by 4
Explaining Medical Cannabis Diversion Among Medical Cannabis License Holders: A Moderation Model
Ne’eman-Haviv, V., & Paz, R. (2024) · Crime & Delinquency · doi:10.1177/00111287241237980 · Cited by 4
Neuromodulation for Cannabis Use: A Scoping Review
Ngoy, A., Tang, V. M., Xiao, K., Blumberger, D. M., George, T. P., Gowin, J. L., Foll, B. L., & Sloan, M. E. (2024) · Brain Sciences · doi:10.3390/brainsci14040356 · Cited by 4
Cognitive Dysfunction in the Addictions (CDiA): protocol for a neuron-to-neighbourhood collaborative research program
Nikolova, Y. S., Ruocco, A. C., Felsky, D., Lange, S., Prévot, T. D., Vieira, É. L. M., Voineskos, D., Wardell, J. D., Blumberger, D. M., Clifford, K. P., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1455968 · Cited by 6
Cannabis Use Disorder Not Associated With Opioid Analgesic Use or Patient-Reported Outcomes After ACL Reconstruction: A Retrospective Matched-Cohort Analysis
Shankar, D. S., DeClouette, B., Vasavada, K. D., Avila, A., Strauss, E. J., Alaia, M. J., & Gonzalez-Lomas, G. P. (2023) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381231190391 · Cited by 4
Cannabis Dependence is Associated with Reduced Hippocampal Subregion Volumes Independently of Sex: Findings from an ENIGMA Addiction Working Group Multi-Country Study
Lorenzetti, V., Gaillard, A., McTavish, E., Grace, S., Rossetti, M. G., Batalla, A., Bellani, M., Brambilla, P., Chye, Y., Conrod, P., et al. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0204 · Cited by 5
Impact of Amphetamine and Captagon abuse on the liver and renal function
Dakil, A. K., & Hasan, A. H. (2024) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2024.1.4 · Cited by 4
Impaired Ghrelin Signaling Does Not Lead to Alterations of Anxiety-like Behaviors in Adult Mice Chronically Exposed to THC during Adolescence
Šestan-Peša, M., Shanabrough, M., Horváth, T. L., & Miletta, M. C. (2023) · Biomedicines · doi:10.3390/biomedicines11010144 · Cited by 5

Authors: Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D.
Affiliations: The University of Queensland (AU)
LMU Klinikum (DE)
Dartmouth College (US)
Corresponding author: Connor, Jason P.
ORCID: Connor, Jason P.
Stjepanović, Daniel
Budney, Alan J.
Hall, Wayne D.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2021-02-25
Volume: 7
Issue: 1
Pages: 16-16
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-021-00247-4
PMC: PMC8655458
OpenAlex: W3131397527
Cited by: 552
References: 341
Citations by year: 2026: 106 · 2025: 135 · 2024: 119 · 2023: 122 · 2022: 49 · 2021: 21
FWCI: 9.85
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (R01DA050032, T32DA037202, P30DA029926)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: cannabis use disorder, cannabis use, cognitive behavioral therapy, motivational enhancement therapy, contingency management, abstinence, cannabinoid receptor agonists, pharmacotherapy, psychiatric comorbidity, substance use disorders, cannabis legalization, medical cannabis, non-medical cannabis, public health burden
MeSH terms: Analgesics, Cannabis, Marijuana Abuse, Humans, Cognitive Behavioral Therapy, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabis use and cannabis use disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks